Dr Magnus Nicolson MBA FRSC FRSM : Chairman
Magnus has been a CEO,COO and General Manager of Life Science companies in Europe the US and the Gulf. As COO he listed a company on AMEX. Several small companies he ran have been sold to leading multinationals. He has degrees in Biochemistry, Immunology (MSc &PhD) and an MBA and has taken products all the way from the laboratory to market.
Prof. W. H. Stimson FRSE: CSO
Bill is the founder of the Department of Immunology at The University of Strathclyde. He has been involved in eight start-up/spin-out biotech companies. He has been a long -term consultant to five multinational companies including Akzo Nobel, Rhone-Poulenc and Johnson & Johnson. Bill has published 215 scientific papers and 25 patents. He was involved in the use of the first human monoclonal antibodies for cancer therapy
Dr Chris McKenzie: Senior Scientist
Chris holds a BSc(Hons) in Genetics and a PhD in Cell Biology. He has worked in the Czech Republic and in Canada at the Canadian Blood Services, Toronto.
Kevin is a serial technology entrepreneur with over 30 years experience. He has successfully established and exited a number of technology businesses. Kevin established the EOS Technology Investment Syndicate in 2014 which is a group of private angel investors focused on early stage science and technology opportunities
Martin is a CIMA qualified accountant and has worked in both Canada and the UK. He provides director-level financial and administrative services to a range of clients in the small and medium-sized enterprise sector
Prof Stimson and Dr Nicolson also serve on the Board and new 'NXDs’ will be added in the near future.
Scientific and Medical Advisors
ILC Therapeutics™ is supported by a Scientific Advisory Board led by Professor Bill Stimson and consists of the following experts and practitioners from industry and academia
Professor Kathryn Ball – Professor of Biochemistry & Cell Signalling at the Institute of Genetics and Molecular Medicine at the University of Edinburgh
Professor Ted Hupp – Chair of Experimental Cancer Research at the University of Edinburgh
Professor David Burden – Clinician & Honorary Professor of Dermatology at the Institute of Infection, Immunity and Inflammation at the University of Glasgow